The leader of the pack has come around on Novartis' ($NVS) flu vaccines. The company said authorities in Italy have lifted a ban on a number of Novartis vaccines there. Italy had imposed the bans two weeks ago after the company informed authorities that it had pulled one batch of the vaccine because it contained elevated protein aggregates. The vaccine is made at a plant in Siena, Italy. Article